Blue Jet Healthcare Schedules Q1 Earnings Call For August 3 At 5:30 PM
NiveshIQ
NSE: BLUEJET · Healthcare
Blue Jet Healthcare Ltd.
₹602.75▲ ₹30.80 (+5.39%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on BLUEJET. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Blue Jet Healthcare Ltd.
Blue Jet Healthcare Limited is a leading Indian pharmaceutical company that engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. The company provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. Its key revenue drivers include the sale of pharmaceutical intermediates and APIs, with a strong presence in the Indian and international markets. Recent developments include the announcement of a ₹10,000 Cr fundraise plan, declaration of a dividend, and strong contrast media sales in Q4 2026. The com
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹710.32 Cr -1.40% | ₹1,026 Cr +44.50% | ₹947.32 Cr -7.70% |
| EBITDA Margin | 34.96% | 42.98% | 38.29% |
| Net Profit | ₹163.75 Cr +2.30% | ₹305.20 Cr +86.40% | ₹247.82 Cr -18.80% |
| EPS | ₹9.44 | ₹9.07 | ₹14.29 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Blue Jet Healthcare Schedules Q1 Earnings Call For August 3 At 5:30 PM
Blue Jet Healthcare Q1 Results: Earnings Call Set for August 3
🔒
+ 3 more stories about Blue Jet Healthcare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹235 Cr, PAT ₹64 Cr, EPS ₹3.71, EBITDA margin 40.1%. Growth context: revenue QoQ +22.0%, PAT QoQ +60.2%. Street verdict: inline, revenue surprise -5.4%, PAT surprise -1.7%.
Product pipeline delivery, domestic demand, export mix, approvals, and margin discipline remain the key forward drivers ...
FY26 (last completed FY): revenue ₹947 Cr, PAT ₹248 Cr, EBITDA margin 38.3%, EPS ₹14.29. Year-on-year: revenue YoY -7.7%...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for BLUEJET
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track BLUEJET alongside your other holdings
Unlock full BLUEJET research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Blue Jet Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Blue Jet Healthcare Ltd. (BLUEJET) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Blue Jet Healthcare Ltd.?
Blue Jet Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹851,715.2L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.